FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Cotter Ann 2. Date of Event Requiring Statement (MM/DD/YYYY)
8/14/2020 

3. Issuer Name and Ticker or Trading Symbol Zomedica Pharmaceuticals Corp. [ZOM]
(Last)       (First)       (Middle)
C/O ZOMEDICA PHARMACEUTICALS CORP., 100 PHOENIX DRIVE, SUITE 180
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Interim CFO /
(Street)
ANN ARBOR, MI 48018      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (1) 3/14/2025  Common Stock, without par value  200000  $0.19  D   
Stock Option (right to buy)  1/10/2019 (2) 1/10/2021  Common Stock, without par value  50000  $1.52  D   

Explanation of Responses:
(1)  The options vest as to 25% on March 14, 2020, with 25% to vest annually thereafter.
(2)  The options vested upon grant. The option is currently fully vested.

Remarks:
Exhibit List Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cotter Ann
C/O ZOMEDICA PHARMACEUTICALS CORP.
100 PHOENIX DRIVE, SUITE 180
ANN ARBOR, MI 48018


Interim CFO

Signatures
/s/ Ann Cotter 8/14/2020
**Signature of Reporting Person Date
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Zomedica Charts.
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Zomedica Charts.